hydrogen sulfide has been researched along with 2-phenyl-4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hwang, SY; O, K; Prathapasinghe, G; Siow, YL; Wu, N; Xu, Z | 1 |
| Bertlein, S; Böltz, S; Filipovic, MR; Herrmann, M; Macinkovic, I; Miljkovic, JLj; Muñoz, LE; Wedmann, R | 1 |
2 other study(ies) available for hydrogen sulfide and 2-phenyl-4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide
| Article | Year |
|---|---|
Ischemia-reperfusion reduces cystathionine-beta-synthase-mediated hydrogen sulfide generation in the kidney.
Topics: Animals; Apoptosis; Cyclic N-Oxides; Cystathionine beta-Synthase; Cystathionine gamma-Lyase; Disease Models, Animal; Free Radical Scavengers; Homeostasis; Homocysteine; Hydrogen Sulfide; Imidazoles; Kidney; Male; Nitric Oxide; Rats; Rats, Sprague-Dawley; Reperfusion Injury | 2009 |
Working with "H2S": facts and apparent artifacts.
Topics: Artifacts; Cell Line, Tumor; Cyclic N-Oxides; Humans; Hydrogen Sulfide; Imidazoles; Membrane Potential, Mitochondrial; Nitric Oxide; Research Design; Superoxides | 2014 |